Concepedia
Statistics
Publications
10
Citations
677
H-Index
Active since
1994
Affiliations
Roche (Japan)(Current)
The University of Tokyo
Novartis (Japan)
Janssen (Belgium)
Novartis (Switzerland)
Yuko Tsukamoto is an author at Roche (Japan) specializing in pharmacokinetics, pharmacology, and pharmacy.
Publications per year
1994–2013
A mechanism‐based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab
Naoto Hayashi, Yuko Tsukamoto, William M. Sallas et al. · British Journal of Clinical Pharmacology · 2006 · 171 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +17
Histone H3 K36 Methylation Is Associated with Transcription Elongation in <i>Schizosaccharomyces pombe</i>
Stephanie A. Morris, Yoichiro Shibata, Ken-ichi Noma et al. · Eukaryotic Cell · 2005 · 126 citations · Full text
Life Sciences, Genetics, Molecular Biology +17
The Intestinal First-pass Metabolism of Substrates of CYP3A4 and P-glycoprotei—Quantitative Analysis Based on Information from the Literature
Motohiro Kato, Kōji Chiba, Akihiro Hisaka et al. · Drug Metabolism and Pharmacokinetics · 2003 · 91 citations
Medicine, Pharmacokinetics, Pharmacology +13
Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data?
Kiyomi Ito, Kōji Chiba, Masato Horikawa et al. · AAPS PharmSci · 2002 · 86 citations · Full text
A Physiologically Based Pharmacokinetic Analysis of Capecitabine, a Triple Prodrug of 5-FU, in Humans: The Mechanism for Tumor-Selective Accumulation of 5-FU
Yuko Tsukamoto, Yukio Kato, Masako Ura et al. · Pharmaceutical Research · 2001 · 85 citations
Medicine, Pharmacokinetics, Pharmacology +15
1–5 of 10